Form D · Other

Outpost Medicine, LLC

Indianapolis, IN · CIK 0001670469

Offering snapshot reported Oct 12, 2018 · SEC filing

Reported sold
$56M
Offering amount: $56M
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 15, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$28M$56MMay 30, 2017: $14,999,999.00May 30, 2017Oct 12, 2018: $55,999,999.00Oct 12, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$14,999,999 → $55,999,999
  • Reported investors10 → 11

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 12, 2018Amendment$55,999,999$41,000,000vs May 30, 201711SEC filing
May 30, 2017Initial$14,999,999No comparison10SEC filing
Mar 29, 2016Initial$15,543,778No comparison10SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-287636

Source: Form D, filed Oct 12, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Bisgaard Director
Scott Byrd Director, Executive
Daniel Estes Director
Terry Gould Director
Peter Moldt Director
David A Socks Director, Promoter
Tadataka Yamada Director
Chen Yu Director

Issuer details

Industry: Other (See others in industry)

Address:
450 East 96th Street Suite 500
Indianapolis, IN, 46240